WHISTLE DOCTOR BLOWING HARD
To Orwell Today,
re: WHISTLEBLOWING WHISTLES WANTED
I really liked some of the articles on your Orwell page. I was drawn by the "wanted whistle" that came up on google. I liked the title.
I'm a medical doctor and researcher involved in a very high profile battle with Procter and Gamble over pharmaceutical research fraud.
There are some links below my signature if you are interested.
Dr Aubrey Blumsohn
Greetings Doctor Blumsohn,
Thanks for the links to your whistle-blowing woes which are for a worthwhile cause worldwide.
In case you haven't come across it yet, there's an Orwell Today section entitled BIO-CHEM WARFARE which contains articles about medical and pharmaceutical travesties.
All the best,
PS - You being a bone doctor I bet your enemies have "a few bones to pick" with you
Aubrey sends a link to his whistle-blowing blog on the pharmaceutical industry
Watchdog eyes scientific fraud. THES: 14 April 2006
Panel to expose fraudulent medical research. The Guardian: Alexandra Smith April 12, 2006
MHRA needs to be examined next. The Independent: Letters 10 April 2006
Payout in P & G drug data row. THES: Published: 07 April 2006
Britain: Drug trial leaves volunteers seriously ill (Scientist attacks lax regulatory regime). Chris Talbot, 29 March 2006, World Socialist Web Site
Bone researcher charges P & G with continuing data concealment. 1 March 2006
Researchers to get a bill of rights from P & G. Times Higher: February 24th 2006
Half hour long BBC Radio Broadcast. Vivienne Parry investigates if Proctor and Gamble attempted to boost the sales of one of its drugs by hindering independent scientific research (23 Feb 2006).
Experts cast doubt over scientists' claims for Actonel. Times Higher: published 24 February 2006
Efficacy of Osteoporosis Medicine Challenged. Richard Harris (NPR Radio, USA)
A British scientist has been in the United States this week alleging that a big drugmaker has been playing fast and loose with data to make its medicine look good. The drug in question is Actonel, used for treating osteoporosis and a big earner for Procter & Gamble.
Scientist Presses Claim P&G Misrepresented Actonel Data. Sarah Ellison, February 23, 2006, The Wall Street Journal
Interview Radio New Zealand (23 minutes) Aubrey Blumsohn, Suspended bone metabolism expert on Drug Companies
Data row sparks research debate. Times Higher Education Supplement: 25 Nov 05
When access to data is a real bone of contention. Times Higher Education Supplement: 25 Nov 05
Doctor accuses drugs giant of 'unethical' secrecy. Observer: 4th Dec 05
How the drugs giant and a lone academic went to war. Observer: 4th Dec 05
Journals reject tougher checks on data. THES: published 20 January 2006
Journal warned about P & G data. THES: 09 December 2005
Calls for probe into Sheffield's relationship with the drug industry. THES: 16 December 2005
Correspondence in Observer. 11 Dec 2005
Whistleblower wins drugs study inquiry. Observer: 11 Dec 05
Gag money rejected. THES: 16 Dec 05
Did a British university sell out to Procter & Gamble? Slate: Dec 22 05
British scientist challenges pharmaceutical company over research paper. Chris Talbot, World Socialist Web Site: 28 January 2006
Doctor in drug research row quits NHS post. The Observer: Jo Revill, Sunday January 15, 2006
Researchers to get a bill of rights from P & G. THES: February 24th 2006
There are also some excellent take off's of the material and the political importance of this case on some excellent pharmaceutical blogs. See especially (in approximate time order):
Consumers Union & Pharma Watch & Pharma Gossip & Brand Trainers & Pharma Watch & Pharma Gossip & Pharma Gossip & Pharma Gossip & Pharma Gossip & H C Renewal
Very efficient. You really spent some effort reformatting those links.
Thanks for the support (all in response to a random email of appreciation to a web owner) and thanks for a great collection of essays.
...and thank you for being a whistle.
All the best,
~ an independent researcher monitoring local, national and international events ~
website: www.orwelltoday.com & email: email@example.com